Table 2.
Peaks in anomalous difference maps
| Data set | Maximum peak height, units of σ | Normalized peak height*
|
||||
|---|---|---|---|---|---|---|
| bH | bL | c1 | FeS† | Next-highest peak | ||
| Native 1 | 14.7 | 1.00 | 0.99 | 0.53 | 0.45 | 0.28 |
| Native 2 | 27.6 | 1.00 | 0.93 | 0.61 | 0.47 | 0.18 |
| Antimycin A | 14.3 | 1.00 | 1.09 | 0.78 | 0.60 | 0.40 |
| MOA-stilbene | 14.2 | 1.00 | 1.02 | 0.76 | — | 0.53‡ |
| UHDBT | 13.3 | 1.00 | 0.89 | 0.61 | 0.97 | 0.34 |
| Stigmatellin | 18.8 | 1.00 | 0.99 | 0.79 | 1.18 | 0.28 |
| Antimycin A + MOA-stilbene | 29.2 | 1.00 | 0.96 | 0.57 | — | 0.20‡ |
| Antimycin A + myxothiazol | 20.1 | 1.00 | 0.97 | 0.66 | 0.38 | 0.24 |
| Antimycin A + UHDBT | 21.8 | 1.00 | 0.77 | 0.60 | 0.83 | 0.32 |
| Antimycin A + stigmatellin | 13.3 | 1.00 | 0.95 | 0.56 | 1.25 | 0.36 |
*
Normalization to bH peak.
†
FeS position in the fixed state.
‡
Possible alternative position of FeS in the loose state.